SRT3
178.35
-1%↓
ORNBV.FI
71.3
+0.49%↑
ROVI.ES
53.1
-0.28%↓
OPM.FR
12.9
+0.08%↑
GLPG
28.84
+0.7%↑
SRT3
178.35
-1%↓
ORNBV.FI
71.3
+0.49%↑
ROVI.ES
53.1
-0.28%↓
OPM.FR
12.9
+0.08%↑
GLPG
28.84
+0.7%↑
SRT3
178.35
-1%↓
ORNBV.FI
71.3
+0.49%↑
ROVI.ES
53.1
-0.28%↓
OPM.FR
12.9
+0.08%↑
GLPG
28.84
+0.7%↑
SRT3
178.35
-1%↓
ORNBV.FI
71.3
+0.49%↑
ROVI.ES
53.1
-0.28%↓
OPM.FR
12.9
+0.08%↑
GLPG
28.84
+0.7%↑
SRT3
178.35
-1%↓
ORNBV.FI
71.3
+0.49%↑
ROVI.ES
53.1
-0.28%↓
OPM.FR
12.9
+0.08%↑
GLPG
28.84
+0.7%↑
24h
Actual
Mínimo
11
Máximo
11.8
Ingresos | -6.9M 7.1M |
---|---|
Ventas | -9.8M 415M |
P/B Media del Sector | 20 40.048 |
BPA | 0.107 |
Rentabilidad por dividendo | 0.84 |
Margen de beneficio | 1.72 |
Empleados | 18,819 |
EBITDA | -14M 25M |
Rentabilidad por dividendo Media del Sector | 0.84% 2.45% |
---|---|
Próximas Ganancias | 7 ago 2025 |
Capitalización de Mercado | -120M 810M |
---|---|
Apertura anterior | 12.87 |
Cierre anterior | 11.1 |
By Trading Central
Confianza
Very Strong Bearish Evidence
N/A / 15.2 Soporte y Resistencia
El rendimiento pasado no es un indicador fiable de resultados futuros.
4 ago 2025, 21:42 UTC
Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone
DJ
Leer
4 ago 2025, 21:21 UTC
Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update
DJ
Leer
4 ago 2025, 20:45 UTC
Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb
DJ
Leer
4 ago 2025, 19:15 UTC
TransMedics Group Shares Rise on FDA Approval for Clinical Trial
DJ
Leer
4 ago 2025, 23:41 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Leer
4 ago 2025, 23:41 UTC
Nikkei May Rise on Fed Stimulus Hopes
DJ
Leer
4 ago 2025, 23:28 UTC
Global Equities Roundup: Market Talk
DJ
Leer
4 ago 2025, 23:28 UTC
Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk
DJ
Leer
4 ago 2025, 21:30 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com
DJ
Leer
4 ago 2025, 21:21 UTC
Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com
DJ
Leer
4 ago 2025, 21:18 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com
DJ
Leer
4 ago 2025, 20:25 UTC
India Hits Back Over Russian Oil Purchases -- Market Talk
DJ
Leer
4 ago 2025, 20:25 UTC
Transocean 2Q Loss $938M >RIG
DJ
Leer
4 ago 2025, 20:25 UTC
Transocean 2Q Loss/Shr $1.06 >RIG
DJ
Leer
4 ago 2025, 20:18 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com
DJ
Leer
4 ago 2025, 20:15 UTC
Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX
DJ
Leer
4 ago 2025, 20:14 UTC
Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX
DJ
Leer
4 ago 2025, 20:14 UTC
Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX
DJ
Leer
4 ago 2025, 20:14 UTC
Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX
DJ
Leer
4 ago 2025, 20:13 UTC
Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX
DJ
Leer
4 ago 2025, 20:09 UTC
Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM
DJ
Leer
4 ago 2025, 20:06 UTC
Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com
DJ
Leer
4 ago 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Net $1.03B >VRTX
DJ
Leer
4 ago 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX
DJ
Leer
4 ago 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX
DJ
Leer
4 ago 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX
DJ
Leer
4 ago 2025, 19:41 UTC
U.S. Natural Gas Futures Settle Lower -- Market Talk
DJ
Leer
4 ago 2025, 19:28 UTC
U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk
DJ
Leer
4 ago 2025, 19:07 UTC
Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk
DJ
Leer
4 ago 2025, 18:27 UTC
Gold Climbs on Rate Cut Speculation -- Market Talk
DJ
Leer
Cambio de precio
By TipRanks
0 ratings
0
Comprar
0
Mantener
0
Vender
De acuerdo con 0 analistas que ofrecen calificaciones bursátiles a para RHOEN-KLINIKUM AG Dist en los últimos 3 meses.
By Trading Central
Corto Plazo
Very Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Medio plazo
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Largo Plazo
Neutral Evidence
The bullish and bearish events are balanced.
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$